Physician profile

Patrick Scott Reames

Interventional Cardiology · New Bern, NC

NPI 1346544152

$4,973.46

in general payments reported to CMS, 2019-2025

30 companies · $725 in 2025

The $725 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,457.14

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Edwards Lifesciences Corporation $1,543.42 2021-2024 Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia
Actelion Pharmaceuticals US, INC. $460.57 2021-2025 Uptravi, Opsumit, Opsynvi
Medtronic, INC. $453.41 2021-2025 Onyx Frontier, Linq II, Micra
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $397.02 2019-2025 Lifevest
Novartis Pharmaceuticals Corporation $278.99 2019-2024
E.R. Squibb & Sons, L.L.C. $238.20 2022-2025 Camzyos
Boston Scientific Corporation $234.09 2019-2024 Lux-Dx Insertable Cardiac Monitor, Ekosonic
Inari Medical, INC. $173.90 2023 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Philips North America LLC $165.78 2024-2025 Coronary Other, Ambulatory Monitoring & Diagnostics Undivided, (Ck4) Mcot
Hitachi Healthcare Americas Corp. $165.74 2020
Janssen Pharmaceuticals, INC $162.06 2019-2024 Xarelto
Novo Nordisk INC $101.97 2025 Ozempic
United Therapeutics Corporation $75.72 2024-2025 Tyvaso, Orenitram
Abbott Laboratories $75.46 2019
Cardiva Medical, INC. $48.65 2023 Cardiva Vascade Mvp Vvcs 6-12f
Show all 30 companies
CompanyGeneral paymentsYearsTop products
Abiomed $46.74 2022
Pfizer INC. $46.23 2021-2025
Kiniksa Pharmaceuticals International, Plc $44.08 2024 Arcalyst
Merck Sharp & Dohme LLC $43.13 2023-2025 Verquvo
Biosense Webster, INC. $40.79 2022-2023 Carto 3
Amgen INC. $26.26 2020
Stryker Corporation $25.99 2025 Flowtriever
Sanofi-Aventis U.S. LLC $21.75 2019
Lexicon Pharmaceuticals, INC. $19.05 2024
Esperion Therapeutics, INC. $15.69 2024 Nexletol
Boehringer Ingelheim Pharmaceuticals, INC. $15.05 2019
Astrazeneca Pharmaceuticals Lp $14.36 2019
Alnylam Pharmaceuticals INC. $14.31 2021
Arbor Pharmaceuticals, INC. $12.62 2019
Siemens Medical Solutions USA, INC. $12.43 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Patrick Scott Reames

$4,973.46

in general payments reported 2019-2025

Years
2019-2025
Top company
Edwards Lifesciences Corporation
Context
The $725 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/333361/patrick-scott-reames

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.